Search research articles
Contact Us
Filters
Showing results (1071-1080 of 1,132) with videos related to
Page
of 114
Sort By:
The Journal of Urology
|
March 3, 2009
Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline
Barnett S Kramer, Karen L Hagerty, Stewart Justman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2009
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline
Barnett S Kramer, Karen L Hagerty, Stewart Justman, et al.
The American Journal of Surgical Pathology
|
July 16, 2014
Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conference
Mahul B Amin, Jonathan I Epstein, Thomas M Ulbright, et al.
American Journal of Clinical Pathology
|
February 27, 2024
Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in Grade Group 2 and 3 cancers
Oleksandr N Kryvenko, Jonathan I Epstein, Ali Merhe, et al.
Clinical Nuclear Medicine
|
January 24, 2017
Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses
Sara Sheikhbahaei, Christopher S Jones, Kristin K Porter, et al.
The American Journal of Pathology
|
October 29, 2022
Genomic Characterization of Prostatic Basal Cell Carcinoma
Jin-Yih Low, Minjeong Ko, Brian Hanratty, et al.
Human Pathology
|
February 15, 2001
Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists
W C Allsbrook, K A Mangold, M H Johnson, et al.
American Journal of Clinical Pathology
|
January 29, 2013
A broad survey of cathepsin K immunoreactivity in human neoplasms
Gang Zheng, Guido Martignoni, Cristina Antonescu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2017
MSH2 Loss in Primary Prostate Cancer
Liana B Guedes, Emmanuel S Antonarakis, Michael T Schweizer, et al.
Human Pathology
|
April 26, 2017
Pericytic tumors of the kidney-a clinicopathologic analysis of 17 cases
Deepika Sirohi, Steven C Smith, Jonathan I Epstein, et al.
Page
of 114
Search research articles
Search
Showing results (1071-1080 of 1,132) with videos related to
Sort By:
Page
of 114
The Journal of Urology
|
March 3, 2009
Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline
Barnett S Kramer, Karen L Hagerty, Stewart Justman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2009
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline
Barnett S Kramer, Karen L Hagerty, Stewart Justman, et al.
The American Journal of Surgical Pathology
|
July 16, 2014
Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conference
Mahul B Amin, Jonathan I Epstein, Thomas M Ulbright, et al.
American Journal of Clinical Pathology
|
February 27, 2024
Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in Grade Group 2 and 3 cancers
Oleksandr N Kryvenko, Jonathan I Epstein, Ali Merhe, et al.
Clinical Nuclear Medicine
|
January 24, 2017
Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses
Sara Sheikhbahaei, Christopher S Jones, Kristin K Porter, et al.
The American Journal of Pathology
|
October 29, 2022
Genomic Characterization of Prostatic Basal Cell Carcinoma
Jin-Yih Low, Minjeong Ko, Brian Hanratty, et al.
Human Pathology
|
February 15, 2001
Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists
W C Allsbrook, K A Mangold, M H Johnson, et al.
American Journal of Clinical Pathology
|
January 29, 2013
A broad survey of cathepsin K immunoreactivity in human neoplasms
Gang Zheng, Guido Martignoni, Cristina Antonescu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2017
MSH2 Loss in Primary Prostate Cancer
Liana B Guedes, Emmanuel S Antonarakis, Michael T Schweizer, et al.
Human Pathology
|
April 26, 2017
Pericytic tumors of the kidney-a clinicopathologic analysis of 17 cases
Deepika Sirohi, Steven C Smith, Jonathan I Epstein, et al.
Page
of 114